Internets Editorial: the true history of Sugar.

How cardiovascular science was diverted for 50 years — and why the correction is finally underway

For decades, Americans were told to fear fat. Meanwhile, sugar—especially fructose—quietly rewired human metabolism, damaged livers, accelerated diabetes, and shortened lives.

This did not happen because the science was unclear. It happened because the science was redirected, then amplified by industrial incentives and regulatory decisions.

This is not a sudden breakthrough. It is America catching up with scientific evidence-based guidelines in the rest of the World..

---

The warning signs came early

Long before “Metabolic Syndrome” had a name, life insurance underwriters, pathologists and clinicians were already observing a consistent pattern: rising refined sugar intake tracked with diabetes, obesity, and coronary heart disease. U.S. community-based investigations in the 1960s—including work from the Tecumseh studies led by Ostrander and colleagues—and parallel British literature notably, Dr John Yudkin’s book, Pure, White and Deadly, 1972, raised early concerns that sugar could be a primary upstream driver of cardiometabolic disease.^[A]

Note: Several mid-1960s sources predate DOI indexing. Where DOIs exist they are listed below; where they do not, citations are included for historical completeness.

---

1966: the moment everything changed

In 1966, a highly influential narrative review in the New England Journal of Medicine reframed coronary heart disease around cholesterol and saturated fat, while minimizing evidence implicating sugar.

This single publication shaped cardiovascular research priorities, dietary guidelines, and professional education for decades.

In 2016, JAMA Internal Medicine revealed that the Sugar Research Foundation had financially influenced the Harvard researchers associated with this cholesterol-focused narrative, steering attention away from sugar and toward fat.^[1]

---

Science and industry moved together

In parallel with the 1966 narrative pivot, researchers at the University of Osaka described enzymatic methods to convert sugars into fructose, laying the biochemical foundation for high-fructose corn syrup (HFCS) production at scale.^[2]  The Clinton Corn Processing Company bought the Japanese patent and brought it to the United States. 

In the early 1970s, U.S. agricultural policy expanded corn subsidies and increased corn surpluses, dramatically lowering the cost of corn-derived sweeteners compared to cane or beet sugars, and enabling HFCS to dominate the food supply.^[B]

---

Regulatory approval without metabolic testing

HFCS then received formal GRAS (Generally Recognized as Safe) status in the United States, based on conventional toxicology standards rather than long-term metabolic or cardiovascular outcomes.  Once a substance is given GRAS status, it can be used in unlimited amounts. 

• HFCS-42: FDA / Federal Register affirmation, May 23 1983 — 48 FR 21530 (21 CFR §184.1866)^[C]
• HFCS-55: Federal Register extension, June 13 1988 — 53 FR 22342^[D]

---

1984: population-level exposure begins

On November 7, 1984, the New York Times reported on page 6 of Section D that Coca-Cola and Pepsi would convert their beverages nationwide from cane sugar to high-fructose corn syrup, permanently altering population-level fructose exposure.^[E]
For the next five dacades, thanks to the diversion of medical research in the United States away from sugar and over to fats and cholesterol, and through generous “sponsorships” of national health organizations who should have known better, the sugar industry was given carte blance to insert fructose and especially, its most toxic version, HFCS into the American food supply, and in this centrury the food supply of the entire world. USDA Dietary Guidelines emphasized “low fat diets”. Fats were replaced by HFCS to restore taste and texture, and prolong shelf life.

---

1998: a new disease finally gets a name

In 1998, the World Health Organization formally defined Metabolic Syndrome, unifying central obesity, insulin resistance, dyslipidemia, hypertension, and glucose intolerance into a single disease entity.^[3]

---

Cardiology catches up

Large prospective cohort studies published in major cardiology journals demonstrated that sugar-sweetened beverage consumption is independently associated with early cardiovascular death, even after adjustment for total calories and body weight.^[4–6]

---

“Alcohol without the buzz”

Robert Lustig and colleagues clarified the mechanistic basis of these observations: fructose is metabolized in the liver in a manner strikingly similar to alcohol, promoting fatty liver, insulin resistance, inflammation, and dyslipidemia—without intoxication to warn the consumer.^[7,8]

---

Why this matters now

This new edition of the USDA dietary guidelines also nudges federal policy and programs (like school meals and feeding programs) toward emphasizing real, nutrient‑rich meals over ultra‑processed convenience options — with major implications for public health initiatives.

Building toward personalization
Although the core DGAs remain population‑level advice, conversations around why the same “healthy plate” works differently from person to person are gaining traction in academic and clinical nutrition circles. This ties into ongoing research suggesting that genes, metabolism, and individual biology help explain varied responses to identical diets — precisely where the next frontier of dietary guidance is headed. (This isn’t yet codified in the DGAs themselves, but it’s steadily entering the research and clinical dialogue.)

In short: the 2025–2030 DGAs mark a firmer break from vague moderation toward clear limits on sugar and processed foods, and they’re positioned at the leading edge of the shift from one‑size‑fits‑all nutrition advice to something that will soon need to account for individual biology and genetics. 

Referrences below are primary sources about  the history of sugar and industry influence on government policy and health organizations.